AMN Antikörper (AA 25-163)
Kurzübersicht für AMN Antikörper (AA 25-163) (ABIN7165044)
Target
Alle AMN Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 25-163
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Protein amnionless protein (25-163AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:500-1:1000, IF:1:200-1:500,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- AMN (Amnionless (AMN))
-
Andere Bezeichnung
- AMN
-
Hintergrund
-
Background: Necessary for efficient absorption of vitamin B12 (PubMed:12590260, PubMed:14576052). Required for normal CUBN-mediated protein transport in the kidney. May direct the production of trunk mesoderm during development by modulating a bone morphogenetic protein (BMP) signaling pathway in the underlying visceral endoderm (By similarity).
Aliases: 5033428N14Rik antibody, amn antibody, Amnion associated transmembrane protein antibody, Amnionless antibody, Amnionless homolog antibody, AMNLS_HUMAN antibody, AV002116 antibody, PRO1028 antibody, Protein amnionless antibody, Type I transmembrane protein antibody, UNQ513/PRO1028 antibody, Visceral endoderm specific type 1 transmembrane protein antibody
-
UniProt
- Q9BXJ7
-
Pathways
- Lipid Metabolism
Target
-